Inovio Pharmaceuticals Inc (INO)
4.065
+0.10
(+2.39%)
USD |
NASDAQ |
Nov 21, 16:00
4.065
0.00 (0.00%)
After-Hours: 20:00
Inovio Pharmaceuticals Total Assets (Quarterly): 107.06M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 107.06M |
| June 30, 2024 | 133.80M |
| March 31, 2024 | 129.11M |
| December 31, 2023 | 170.95M |
| September 30, 2023 | 193.10M |
| June 30, 2023 | 233.04M |
| March 31, 2023 | 266.58M |
| December 31, 2022 | 348.53M |
| September 30, 2022 | 391.97M |
| June 30, 2022 | 459.40M |
| March 31, 2022 | 445.51M |
| December 31, 2021 | 495.94M |
| September 30, 2021 | 535.76M |
| June 30, 2021 | 591.84M |
| March 31, 2021 | 654.86M |
| December 31, 2020 | 539.77M |
| September 30, 2020 | 437.81M |
| June 30, 2020 | 443.19M |
| March 31, 2020 | 338.92M |
| December 31, 2019 | 143.95M |
| September 30, 2019 | 151.53M |
| June 30, 2019 | 165.07M |
| March 31, 2019 | 191.17M |
| December 31, 2018 | 131.11M |
| September 30, 2018 | 140.70M |
| Date | Value |
|---|---|
| June 30, 2018 | 148.92M |
| March 31, 2018 | 173.66M |
| December 31, 2017 | 187.24M |
| September 30, 2017 | 203.68M |
| June 30, 2017 | 158.85M |
| March 31, 2017 | 153.31M |
| December 31, 2016 | 173.71M |
| September 30, 2016 | 194.55M |
| June 30, 2016 | 203.99M |
| March 31, 2016 | 211.29M |
| December 31, 2015 | 213.84M |
| September 30, 2015 | 230.77M |
| June 30, 2015 | 201.70M |
| March 31, 2015 | 117.86M |
| December 31, 2014 | 131.79M |
| September 30, 2014 | 134.53M |
| June 30, 2014 | 142.15M |
| March 31, 2014 | 151.66M |
| December 31, 2013 | 88.29M |
| September 30, 2013 | 88.02M |
| June 30, 2013 | 50.99M |
| March 31, 2013 | 58.20M |
| December 31, 2012 | 45.14M |
| September 30, 2012 | 44.48M |
| June 30, 2012 | 48.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
107.06M
Minimum
Sep 2024
654.86M
Maximum
Mar 2021
353.06M
Average
370.25M
Median
Total Assets (Quarterly) Benchmarks
| Novavax Inc | 1.712B |
| Baxter International Inc | 26.68B |
| AIM ImmunoTech Inc | 13.59M |
| Protalix BioTherapeutics Inc | 61.56M |
| Armata Pharmaceuticals Inc | 98.24M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.52M |
| Shareholders Equity (Quarterly) | 73.54M |